Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P570: Prediction of achieving remission in Crohn's disease patients by abdominal ImagingECCO'21 Virtual
Year: 2021
Authors: Meringer, H.(1);Tzadok, R.(1);Mercer, D.(2);Handler, M.(2);Barnes, S.(2);Waterman, M.(3);Abadi, S.(4);Margalit Yehuda, R.(5);Kopylov, U.(5);Amitai, M.M.(6);Bar-Gil Shitrit, A.(7);Sheynkman, G.(8);Zittan, E.(9);Maharshak, N.(1);
(1)Tel Aviv Sourasky Medical Center and Sackler School of Medicine- Tel Aviv University, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(2)Tel Aviv Sourasky Medical Center and Sackler School of Medicine- Tel Aviv University, Department of Radiology, Tel Aviv, Israel;(3)Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel;(4)Rambam Health Care Campus, Department of Radiology, Haifa, Israel;(5)Sheba Medical Center and Sackler School of Medicine- Tel Aviv University, Division of Gastroenterology, Ramat Gan, Israel;(6)Sheba Medical Center, Department of Radiology, Ramat Gan, Israel;(7)Faculty of Medicine- Hebrew University of Jerusalem, IBD MOM Unit- Digestive Diseases Institute- Shaare Zedek Medical Center, Jerusalem, Israel;(8)Shaare Zedek Medical Center, Department of Radiology, Jerusalem, Israel;(9)Institute of Gastroenterology and Liver Diseases, IBD Unit- Emek Medical Center, Afula, Israel
P571: Optimal biologic management of endoscopic postoperative recurrence following ileocecal resection in Crohn’s diseaseECCO'21 Virtual
Year: 2021
Authors: Bachour, S.(1);Shah, R.(1);Lyu, R.(2);Rieder, F.(1);Cohen, B.(1);Qazi, T.(1);Lashner, B.(1);Achkar, J.P.(1);Philpott, J.(1);Lightner, A.(3);Holubar, S.(3);Regueiro, M.(1);Click , B.(1);
(1)Cleveland Clinic Foundation, Department of Gastroenterology and Hepatology, Cleveland, United States;(2)Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Cleveland, United States;(3)Cleveland Clinic Foundation, Department of Colorectal Surgery, Cleveland, United States
P572: The influence of beliefs about medication in therapeutic adherence among patients with inflammatory bowel disease.ECCO'21 Virtual
Year: 2021
Authors: De Castro Parga, M.L.(1,2);Alvarez-Smith, C.(1);Sanroman, L.(1);Figueira, M.(1);Hernández, V.(1);Pineda, J.(1);Martinez-Cadilla, J.(1);Pereira, S.(1);Rodriguez-Prada, I.(1);
(1)University Hospital Complex of Vigo, Department of Gastroenterology, Vigo, Spain;(2)Instituto de Investigación Sanitaria Galicia Sur IIS Galicia Sur., Sergas, Vigo, Spain
P573: Comparative effectiveness of second-line biological therapies for Ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatmentECCO'21 Virtual
Year: 2021
Authors: Hyun, H.K.(1);Yu, J.(1);Kang, E.A.(1);Park, J.(1);Park, S.J.(1);Park, J.J.(1);Kim, T.I.(1);Kim, W.H.(1);Cheon, J.H.(1);
(1)Yonsei University College of Medicine, Gastroenterology, Seoul, Korea- Republic Of
P574: Exploring treatment of Crohn’s disease and ulcerative colitis in the Middle East and Northern Africa: An analysis of the HARIR observational cohort studyECCO'21 Virtual
Year: 2021
Authors: Hamed, W.(1);Salem, O.E.(2);Alharbi, O.(3);,4;Sharaf, M.(5);Taylor, C.(6);Sherief, A.(7);Besar, A.(6);
(1)Ain Shams University Hospital, Department of Tropical Medicine, Cairo, Egypt;(2)Osama Ebada GI Center, Department of Internal Medicine, Alexandria, Egypt;(3)King Saud University, College of Medicine, Riyadh, Saudi Arabia;(4)King Khalid University Hospital, College of Medicine, Riyadh, Saudi Arabia;(5)Janssen, Medical Affairs, Jeddah, Saudi Arabia;(6)Janssen, Medical Affairs, Dubai, United Arab Emirates;(7)Janssen, Medical Affairs, Cairo, Egypt
P575: Nutrition and Inflammatory Bowel Disease – a nationwide survey of patients, gastroenterologists and dietitiansECCO'21 Virtual
Year: 2021
Authors: McCarthy, N.(1);Schultz, M.(2);Wall, C.(1);
(1)University of Otago- Christchurch, Department of Medicine, Christchurch, New Zealand;(2)University of Otago, Department of Medicine, Dunedin, New Zealand
P576: Ustekinumab levels correlate with induction fecal calprotectin drop-slope and discriminate the need for intensification at week 52 in Crohn's Disease patients.ECCO'21 Virtual
Year: 2021
Authors: Mateos, B.(1);Sáez-González, E.(2);Iborra, M.(2);Moret, I.(1);Cañada, A.(3);Tortosa, L.(1);Bastida, G.(2);Aguas, M.(2);Cerrillo, E.(2);Nos, P.(2);Beltrán, B.(2);
(1)Health Research Institute La Fe, Inflammatory Bowel Disease, Valencia, Spain;(2)La Fe Hospital, Gastroenterology, Valencia, Spain;(3)Health Research Institute La Fe, Biostatistics, Valencia, Spain
P577: Withdrawal of thiopurines in patients with Ulcerative Colitis in remissionECCO'21 Virtual
Year: 2021
Authors: Amor Costa, C.(1);Suárez Ferrer, C.(1);Poza Cordón, J.(1);Rueda García, J.L.(1);Sánchez Azofra, M.(1);Martín Arranz, E.(1);González Diaz, I.(1);Amiama Roig, C.(1);García Ramirez, L.(1);Martín Arranz, M.D.(1);
(1)Hospital La Paz Institute for Health Research - IdiPAZ La Paz University Hospital - Universidad Autónoma de Madrid, Gastroenterology and Hepatology, Madrid, Spain
P578: Adriatic-Balkan regional survey on COVID-19 in Inflammatory Bowel Disease patientsECCO'21 Virtual
Year: 2021
Authors: Borzan, V.(1,2);Orsic Fric, V.(1,2);Borzan, B.(3);
(1)Clinical Hospital Centre Osijek, Department of Gastroenterology and Hepatology, Osijek, Croatia;(2)Faculty of Medicine- J. J. Strossmayer University of Osijek, Department of Internal Medicine, Osijek, Croatia;(3)Community Health Center Osijek, Department of Occupational Medicine, Osijek, Croatia
P579: Online Education Significantly Improved Gastroenterologists' Knowledge of Treatment Options and Therapeutic Goals in Ulcerative ColitisECCO'21 Virtual
Year: 2021
Authors: Bell, E.(1);Calle, M.(2);Vermeire, S.(3);
(1)WebMD, Medscape Educational Global, London, United Kingdom;(2)WebMD, Medscape Education Global, Amsterdam, The Netherlands;(3)University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium
P580: Benchmarking IBD Pharmacy Services to optimise, strengthen and align IBD Expert Pharmacy PracticeECCO'21 Virtual
Year: 2021
Authors: St Clair Jones, A.(1);Meade, U.(2);
(1)Brighton and Sussex University Hospitals, Department of Gastroenterology- Department of Pharmacy, Brighton, United Kingdom;(2)St.Mark, Pharmacy, London, United Kingdom; IBDUK
P581: Pre-operative prolonged antibiotic treatment in ileocecal Crohn’s disease: single center non-randomized prospective study.ECCO'21 Virtual
Year: 2021
Authors: Vardanyan, A.(1);Ovsyannikova, V.(2);Peda , E.(3);Nanaeva, B.(3);Achkasov, S.(4);
(1)National medical research center of Coloproctology, IBD surgical department, Moscow, Russian Federation;(2)National medical research center of Coloproctology, IBD surgery department, Moscow, Russian Federation;(3)National medical research center of Coloproctology, Gastroenterology, Moscow, Russian Federation;(4)National medical research center of Coloproctology, Oncology and Colon Surgery Department, Moscow, Russian Federation
P582: Insights on the sphingolipid profile in patients with short bowel syndrome and consecutive intestinal failureECCO'21 Virtual
Year: 2021
Authors: Kubesch, A.(1);Knauer, F.(1);Thomas, D.(2);Jakobi, K.(3);Filmann, N.(4);Zeuzem, S.(1);Pfeilschifter, J.(3);Grammatikos, G.(1);Blumenstein, I.(1);
(1)Goethe-University Hospital, Department of Internal Medicine 1, Frankfurt, Germany;(2)Goethe-University Hospital, Institute of Clinical Pharmacology, Frankfurt, Germany;(3)Goethe-University Hospital, Institute of General Pharmacology and Toxicology, Frankfurt, Germany;(4)Goethe-University Hospital, Institute of Biostatistics and Mathematical Modeling, Frankfurt, Germany
P583: Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort studyECCO'21 Virtual
Year: 2021
Authors: Mocci, G.(1);Cuomo, A.(2);Allegretta, L.(3);Aragona, G.(4);Colucci, R.(5);Della Valle, N.(6);Ferronato, A.(7);Forti, G.(8);Gaiani, F.(9);Graziani, M.G.(10);Lorenzetti, R.(11);Luzza, F.(12);Penna, A.(13);Pica, R.(14);Piergallini, S.(15);Rodinò, S.(16);Scarcelli, A.(17);Zampaletta, C.(18);Cicerone, C.(19);Cocco, A.(20);De Angelis, G.(9);Donnarumma, L.(2);Pranzo, G.(21);Franceschi, M.(7);Gallina, S.(18);Grasso, G.(3);Larussa, T.(12);Luppino, I.(22);Faggiani, R.(23);Fanigliulo, L.(24);Pagnini, C.(10);Perazzo, P.(4);Sacco, R.(6);Sebkova, L.(16);Serio, M.E.(25);De Monti, A.(26);Picchio, M.(27);Elisei, W.(28);Maconi, G.(26);Tursi, A.(29);
(1)Gastroenterology Unit, Internal Medicine- Brotzu Hospital, Cagliari, Italy;(2)Division of Gastroenterology, Umberto I” Hospital, Nocera Inferiore, Italy;(3)Division of Gastroenterology, 'Santa caterina Novella' Hospital, Galatina, Italy;(4)Division of Gastroenterology, 'Guglielmo da Saliceto' Hospital, Piacenza, Italy;(5)Digestive Endoscopy Unit, 'San Matteo degli Infermi' Hospital, Spoleto, Italy;(6)Division of Gastroenterology, 'Ospedali Riuniti' Hospital, Foggia, Italy;(7)Digestive Endoscopy Unit, ULSS7 Pedemontana, Santorso, Italy;(8)Digestive Endoscopy Unit, 'S. Maria Goretti' Hospital, Latina, Italy;(9)Gastroenterology and Endoscopy Unit, Department of Medicine and Surgery- University of Parma, Parma, Italy;(10)Division of Gastroenterology, 'san Giovanni-Addolorata' Hospital, Rome, Italy;(11)Division of Gastroenterology, 'Nuovo regina margherita' Territorial Hospital, Rome, Italy;(12)Department of Health Science, University of Catanzaro, Catanzaro, Italy;(13)Territorial Gastroenterology Service, Azienda Sanitaria Locale BA, Bari, Italy;(14)Division of Gastroenterology- IBD Unit, 'S. Pertini'Hospital, Rome, Italy;(15)Division of Gastroenterology- IBD Unit, 'A. Murri' Hospital, Fermo, Italy;(16)Division of Gastroenterology, 'Ciaccio-Pugliese' Hospital, Catanzaro, Italy;(17)Division of Gastroenterology, 'San Salvatore' Hospital, Pesaro, Italy;(18)Division of Gastroenterology, 'Belcolle' Hospital, Viterbo, Italy;(19)Ambulatory of Territorial Gastroenterology, Sanitary Territorial Agency, Cosenza, Italy;(20)Division of Gastroenterology- IBD Unit, 'S. Pertini' Hospital, Rome, Italy;(21)Ambulatory for IBD Treatment, 'Valle D'Itria' Hospital, Martina Franca, Italy;(22)Division of Gastroenterology, 'Annunziata Hospital', Cosenza, Italy;(23)Division of Gastroenterology, 'San Camillo Forlanini' Hospital, Rome, Italy;(24)Division of Gastroenterology, 'SS Annunziata' Hospital, Taranto, Italy;(25)Division of Gastroenterology, 'San Salvatore' Hospital, Pesaro, Italy;(26)Division of Gastroenterology, 'L. Sacco' University Hospital, Milan, Italy;(27)Division of General Surgery, 'P. Colombo' Hospital- Roma 6, Rome, Italy;(28)Division of Gastroenterology, 'S. Camillo Forlanini' Hospital, Rome, Italy;(29)Territorial Gastroenterology Service, Azienda Sanitaria Locale BAT, Andria, Italy
P584: Mucosal Eosinophilia is an Independent Predictor of Vedolizumab Effectiveness in Ulcerative ColitisECCO'21 Virtual
Year: 2021
Authors: Gremida, A.(1);Huang, K.(1);Ciorba, M.(1);Deyali , C.(1);Deepak, P.(1);
(1)Washington University in Saint Louis, Gastroenterology, Saint Louis, United States
P585: IBD Reference and Biosimilar adalimumab CroSS over Study (iBaSS): a mixed methods clinical trial of patients transitioning between originator and biosimilar adalimumab. Qualitative findings from an interim analysis presenting the patient perspective.ECCO'21 Virtual
Year: 2021
Authors: Young, D.(1);Latter, S.(2);Harvey, J.(3);Addison, J.(4);Freudensprung, U.(5);Cummings, F.(1);
(1)University Hospital Southampton NHS Foundation Trust, Department of Gastroenterology, Southampton, United Kingdom;(2)University of Southampton, School of Health Sciences, Southampton, United Kingdom;(3)Stellenbosch University, Department of Statistics and Actuarial Science, Stellenbosch, South Africa;(4)Biogen Idec, n/a, Maidenhead, United Kingdom;(5)Biogen International GmbH, n/a, Baar, Switzerland
P586: Drug-induced lipid changes in patients with Inflammatory Bowel Disease: a single center, prospective studyECCO'21 Virtual
Year: 2021
Authors: SleutjesAM, J.(1);de Vries, A.C.(1);Roeters van Lennep, J.E.(2);van der Woude, C.J.(1);
(1)Erasmus Medical Center, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(2)Erasmus Medical Center, Internal Medicine, Rotterdam, The Netherlands
P587: Utility of intestinal ultrasound in Inflammatory Bowel Disease patients on management decisionsECCO'21 Virtual
Year: 2021
Authors: Abraham, B.(1);Saleh, A.(2);Perry, C.(1);
(1)Houston Methodist Hospital, Gastroenterology, Houston, United States;(2)Texas A&M University, Engineering Medicine, Houston, United States
P588: Steroid sparing effect of adalimumab in cortisone–depended ulcerative colitis patientsECCO'21 Virtual
Year: 2021
Authors: SinaDr., M.(1);Pengili, E.(1);Pemaj, X.(1);Osmanaj, D.(1);Bibolli, I.(1);Prifti, S.(1);
(1)University Hospital Center Mother Theresa, Internal Medicine/ Gastroenterology, Tirana, Albania
P589: Stable Trends in Radiation Exposure Amongst Patients with a New Diagnosis of Inflammatory Bowel Disease at an Irish Tertiary Referral HospitalECCO'21 Virtual
Year: 2021
Authors: Matthews, T.J.(1);
(1)Tallaght University Hospital, Gastroenterology, Dublin 24, Ireland